In a report released today, John Kim from BMO Capital downgraded National Health Investors (NHI) to Sell, with a price target of $74. The company’s shares closed yesterday at $80.38.
According to TipRanks.com, Kim is a 4-star analyst with an average return of 5.0% and a 60.3% success rate. Kim covers the Financial sector, focusing on stocks such as Apartment Investment & Management, Franklin Street Properties, and Columbia Property Trust.
Currently, the analyst consensus on National Health Investors is a Moderate Sell with an average price target of $69.50.
See today’s analyst top recommended stocks >>
National Health Investors’ market cap is currently $3.39B and has a P/E ratio of 21.75. The company has a Price to Book ratio of 2.49.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
National Health Investors, Inc. is a real estate investment trust, which engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.
